Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Change in Cash (2020 - 2025)

NeuroPace has reported Change in Cash over the past 6 years, most recently at $1.0 million for Q4 2025.

  • Quarterly results put Change in Cash at $1.0 million for Q4 2025, up 152.52% from a year ago — trailing twelve months through Dec 2025 was $8.3 million (up 278.52% YoY), and the annual figure for FY2025 was $8.3 million, up 278.52%.
  • Change in Cash for Q4 2025 was $1.0 million at NeuroPace, up from -$2.2 million in the prior quarter.
  • Over the last five years, Change in Cash for NPCE hit a ceiling of $17.2 million in Q2 2021 and a floor of -$12.5 million in Q1 2021.
  • Median Change in Cash over the past 5 years was -$84000.0 (2022), compared with a mean of -$247100.0.
  • Biggest five-year swings in Change in Cash: soared 13400.0% in 2023 and later tumbled 4500.0% in 2024.
  • NeuroPace's Change in Cash stood at -$7.4 million in 2021, then soared by 112.32% to $917000.0 in 2022, then soared by 809.6% to $8.3 million in 2023, then tumbled by 123.83% to -$2.0 million in 2024, then surged by 152.52% to $1.0 million in 2025.
  • The last three reported values for Change in Cash were $1.0 million (Q4 2025), -$2.2 million (Q3 2025), and -$4.2 million (Q2 2025) per Business Quant data.